Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

360.37 -0.94 (-0.26%)
Streaming Delayed Price Updated: 1:34 PM EDT, Oct 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
We Are the Champions: 3 Dividend Growers Wall Street Loves
A way to gain exposure to dividend growers is to invest in a handful of companies across sectors. These are a few of the names research firms like the most. 
Via MarketBeat
Topics ETFs
Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
From Stryker
Via Business Wire
Stryker, Freeport-McMoRan, Southwest Gas And This Health Care Major Feature On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors chose Stryker Corporation (NYSE: SYK), saying all medical procedures that 
Via Benzinga
Is This Dividend Growth Stock a Buy?
The medical devices giant has outperformed the S&P 500 index so far in 2022. 
Via The Motley Fool
Analyst Ratings for Stryker
Via Benzinga
2 Under-the-Radar Medtech Stocks to Buy Now
Don't count out these discounted medical technology stocks. 
Via The Motley Fool
Where Stryker Stands With Analysts
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter: 
Via Benzinga
Peering Into Stryker's Recent Short Interest
Stryker's (NYSE:SYK) short percent of float has fallen 21.33% since its last report. The company recently reported that it has 5.82 million shares sold short, which is 1.66% of all regular shares that... 
Via Benzinga
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
2 Top Healthcare Stocks to Buy Right Now
A growing and aging global population serves as a major tailwind for the healthcare sector. 
Via The Motley Fool
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Why Uber Will Dominate Lyft In Ride-Hailing Space And This MedTech Company Featured On CNBC's 'Final Trades'
On CNBC’s “Halftime Report Final Trades,” Josh Brown of Ritholtz Wealth Management said that it is becoming apparent that Uber Technologies Inc. 
Via Benzinga
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
From Stryker Corporation
Via GlobeNewswire
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. 
Via Benzinga
Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Alibaba To $125? Plus This Analyst Slashes PT On Argo Blockchain By 90%
  Truist Securities slashed the price target on Alibaba Group Holding Limited (NYSE: BABA) from $135 to $125. Alibaba shares rose 6.5% to $67.70 in pre-market trading. 
Via Benzinga
Stryker Reports Q3 Earnings Miss Due To High Component Prices, Cuts Full Year Profit Guidance
Via Benzinga
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQ: ISRG) is turning 22 years old since its U.S. Food and Drug 
Via MarketBeat
Topics Economy
Exposures COVID-19 Interest Rates Supply Chain
Why Goodyear Tire & Rubber Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Gainers Quotient Limited (NASDAQ: QTNT) rose 60.7% to $0.1295 in pre-market trading. Quotient shares dipped 37% on Monday after the company announced a 1-for-40 reverse stock split. 
Via Benzinga
Stryker reports third quarter 2022 operating results
From Stryker Corporation
Via GlobeNewswire
This Industry Titan Is Buying Back Its Stock Hand Over Fist. Should Investors Follow?
Stock buybacks are fantastic for shareholders for several reasons. 
Via The Motley Fool
$100 Invested In Stryker 10 Years Ago Would Be Worth This Much Today
Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 5.19% on an annualized basis producing an average annual return of 15.63%. Currently, Stryker has a market capitalization of... 
Via Benzinga
Markets Turn More Bullish
The CNN Money Fear and Greed index showed further improvement in overall market sentiment after US stocks gained on Friday despite a plunge in Amazon.com (NASDAQ: AMZN) shares. 
Via Benzinga
Global Payments, ON Semiconductor And 3 Stocks To Watch Heading Into Monday
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Earnings Scheduled For October 31, 2022
Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion. 
Via Benzinga
Company Report Roundup: Tesla, Tractor Supply, American Express, and More
Plus a look at investing books, stocks to watch, and other topics for investors. 
Via The Motley Fool
Stryker's Earnings Outlook
Stryker (NYSE:SYK) is set to give its latest quarterly earnings report on Monday, 2022-10-31. Here's what investors need to know before the announcement. Analysts estimate that Stryker will report an... 
Via Benzinga
Can Mid-Cap Lantheus Continue its 2022 Outperformance?
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test. 
Via MarketBeat
Topics ETFs Initial Public Offering
Exposures Securities Market
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.